Entero Healthcare Solutions Limited has informed the Exchange regarding Clarification on Investor Queries relating to profit attributable to owners of the Company and minority interest for the Quarter ended 31st March 2026.
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Entero Healthcare Solutions has clarified investor concerns about modest profit growth and increased minority interest for Q4 FY26. The company reported one-off items totaling INR 114 million impacting profits, including costs from closure of a business contract and higher provisioning charges and write-offs. The increase in non-controlling interest is attributed to the acquisition of Anand Chemiceutics Private Limited during the quarter, where Entero acquired a 51.51% stake. This acquisition resulted in 48.49% minority ownership in that subsidiary, leading to higher minority interest in consolidated financials. The company stated this clarification is for transparency and investor benefit.
The clarification provides transparency on one-time charges affecting quarterly profits but does not change the underlying business outlook. The acquisition-driven minority interest increase is expected to continue as the 51.51% owned subsidiary generates profits.